Acknowledging the need for strengthening cooperation between three Baltic countries to exchange of experiences and establish common approaches in tuberculosis (TB) control in Baltics, as well as to advocate for TB priority areas in countries, the first TB symposium was organised in 2016; Since then Baltic TB symposiums in Riga have become highly anticipated events, each year connecting over 75 participants and high level field experts - TB clinicians, nurses, public health, social service, NGO and patient representatives, as well as the policy makers. 

3rd Baltic Symposium Strenghtening the people-centred model of tuberculosis care for better diagnosis and treatment outcomes

November 23-24, 2018, AVALON Hotel & Conferences, 13.Janvara str. 19, Riga, Latvia

Third Baltic States Symposium was devoted to people-centred model of drug-resistant tuberculosis (DR-TB) care for achieving better treatment outcomes. Main objective of the Symposium was to develop a common memorandum of understanding on how to achieve a best adapted model of care in all three Baltic countries and list of most effective activities to achieve this goal. Program includced digital health solutions for treatment adherence and TB patient empowerment, nursing process - patient education, psycho-emotional support, stigma reduction, upcoming WHO guidelines on the management of DR-TB as well as latent TB infection diagnostic and treatment and molecular methods for TB diagnostic. 

79 participants and facilitators from Latvia, Lithuania, Estonia, The Netherlands, Germany and United Kingdom attended the symposium. 


Memorandum of understanding 

2nd International Baltic Symposium Management of TB/HIV co-infected patients: challenges and opportunities to End TB Strategy

May 19-20, 2017, Radisson Blu Hotel Latvija, 55 Elizabetes street, Riga, Latvia

2nd Baltic States symposium was organised jointly for TB and HIV specialists to introduce with latest developments in management of TB/HIV co-infected patients and prepare country specific list of priority actions for adaptation of these developments in Baltic countries.  Outline of the symposium included latent TB infection diagnostics and treatment experiences in European countries for HIV infected persons, including children, integrated care for TB/HIV affected persons, role of pharmacovigilance and country updates in introduction of new antiTB drugs.

75 participants and facilitators from Denmark, Lithuania, Estonia, Latvia, Italy and The Netherlands attended the event. 


1st Baltic States symposium Introduction of new and repurposed drugs in the programmatic management of DR-TB – from science to practice

23-24 of May, 2016, Conference room of “Biblioteka №1” restaurant, Terbatas street 2, Riga, Latvia 

1st Baltic States symposium was a major step towards scaling up common strategies in Baltic States in safe, rational and effective use of TB  novel drugs, as well as applying new practices and approaches in framework of programmatic management of DR-TB. Objectives of the symposium were to provide an update on current evidence and WHO policy recommendations on the use of new and re-purposed drugs; to discuss the programmatic introduction and future positioning of new drugs – TB patient triage concept, future regimen design, treatment duration; to share experiences and practices from countries using new and re-purposed drugs for adults and children and to decide on common strategies in Baltic states on future improvements of M/XDR-TB management.

More than 70 participants attended the Symposium. Most of them were TB doctors from various settings, including regional hospitals, outpatient departments, penitentiary system and laboratory, involved in introduction of new TB drugs in their respective institutions.